Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$432M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$193M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$95.9M |
| 4 |
Molson Coors Class B
TAP
|
+$28.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$172M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$47.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$21.1M |
| 4 |
Intel
INTC
|
+$20.4M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 2.75% |
| 2 | Technology | 2.62% |
| 3 | Consumer Discretionary | 2.44% |
| 4 | Financials | 1.98% |
| 5 | Healthcare | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fortive
FTV
$18.6B
| $1.02M | 0.01% |
30,275
| – | – |
|
227
Cameco
CCJ
$42.4B
| $1.01M | 0.01% |
96,600
-23,100
| -19% | -$209K |
|
228
O'Reilly Automotive
ORLY
$76.3B
| $1M | 0.01% |
54,000
-148,035
| -73% | -$2.7M |
|
|
CMA
229
DELISTED
Comerica
CMA
| $1M | 0.01% |
+14,700
| New | +$861K |
|
230
CenterPoint Energy
CNP
$26.8B
| $973K | 0.01% |
+39,500
| New | +$924K |
|
231
Sally Beauty Holdings
SBH
$1.58B
| $907K | 0.01% |
+34,319
| New | +$905K |
|
232
Truist Financial
TFC
$64B
| $907K | 0.01% |
+19,300
| New | +$821K |
|
233
Teva Pharmaceuticals
TEVA
$41.2B
| $895K | 0.01% |
24,700
| – | – |
|
234
BorgWarner
BWA
$13.9B
| $878K | 0.01% |
25,285
-56,961
| -69% | -$1.84M |
|
|
ATVI
235
DELISTED
Activision Blizzard
ATVI
| $857K | 0.01% |
23,744
-53,166
| -69% | -$2.13M |
|
|
SPLK
236
DELISTED
Splunk Inc
SPLK
| $670K | 0.01% |
13,100
+2,500
| +24% | +$144K |
|
237
Waste Management
WM
$91B
| $669K | 0.01% |
9,437
-5,426
| -37% | -$363K |
|
238
Corning
GLW
$143B
| $611K | 0.01% |
25,193
-56,707
| -69% | -$1.35M |
|
|
STI
239
DELISTED
SunTrust Banks, Inc.
STI
| $603K | 0.01% |
+11,000
| New | +$549K |
|
240
Edison International
EIX
$26.4B
| $590K | 0.01% |
+8,200
| New | +$579K |
|
241
Federal Realty Investment Trust
FRT
$10.3B
| $583K | 0.01% |
+4,100
| New | +$582K |
|
242
Healthpeak Properties
DOC
$14.8B
| $574K | 0.01% |
+19,300
| New | +$588K |
|
243
M&T Bank
MTB
$36.2B
| $563K | 0.01% |
+3,600
| New | +$487K |
|
244
CME Group
CME
$94.8B
| $519K | ﹤0.01% |
4,500
-5,400
| -55% | -$601K |
|
245
Colgate-Palmolive
CL
$74.4B
| $508K | ﹤0.01% |
+7,768
| New | +$533K |
|
|
FITB
246
Fifth Third Bancorp
FITB
$51.8B
| $485K | ﹤0.01% |
+18,000
| New | +$432K |
|
|
XL
247
DELISTED
XL Group Ltd.
XL
| $469K | ﹤0.01% |
+12,600
| New | +$452K |
|
248
Whirlpool
WHR
$2.82B
| $454K | ﹤0.01% |
2,500
-61,500
| -96% | -$10.2M |
|
249
KeyCorp
KEY
$24.4B
| $422K | ﹤0.01% |
+23,100
| New | +$364K |
|
250
Oceaneering
OII
$4.77B
| $397K | ﹤0.01% |
+14,063
| New | +$379K |
|
Similar funds
Ray Dalio's Q4 2016 Portfolio in Review
As of Q4 2016, Ray Dalio held 377 positions worth $10.5B, up 3.7% from $10.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Ray Dalio deployed $653M of net new capital in Q4 2016, opening 78 new positions and adding to 101 existing holdings. Its largest new stake was UnitedHealth: 163,900 shares worth $26.2M.
By sector, the portfolio is most concentrated in Energy at 2.8% of assets, down from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $172M trimmed.
- Ray Dalio's largest Q4 2016 buy was UnitedHealth: 163,900 shares worth $26.2M.
- Ray Dalio added most to Vanguard FTSE Emerging Markets ETF in Q4 2016, an estimated $432M increase.
- Ray Dalio's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $172M.
- Ray Dalio fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $21.1M.
- Ray Dalio's ten largest holdings make up 83% of its $10.5B portfolio in Q4 2016.
- Ray Dalio opened 78 new positions and closed 110 in Q4 2016.
- Ray Dalio's portfolio value rose 3.7% quarter-over-quarter to $10.5B.
Based on Bridgewater Associates's 13F filing for Q4 2016, filed 10 Feb 2017.